Trial · NCT04171570
DIStal Versus COnventional RADIAL Access for Coronary Angiography and Intervention
NCT04171570, Not applicable, Completed, Terumo Europe N.V.
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. DIStal Versus COnventional RADIAL Access for Coronary Angiography and Intervention. Trials, record NCT04171570. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT04171570
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- DIStal Versus COnventional RADIAL Access for Coronary Angiography and Intervention
- NCT number
- NCT04171570
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 1,309 participants, actual
- Lead sponsor
- Terumo Europe N.V.
- Conditions
- Coronary Disease
- Interventions
- Coronary angiography and or Percutaneous coronary Intervention
- First posted
- 2019-11-21
- Last updated
- 2022-05-24
Source ClinicalTrials.gov
Registered outcomes13
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Forearm radial artery occlusion (RAO) rate before discharge | up to 5 days | Forearm radial artery occlusion (RAO) rate before discharge measured with Doopler Ultrasound |
| Secondary | Rate of successful sheath insertion | up to 2 days | Rate of successful sheath insertion obtained though eCRF question |
| Secondary | Rate of access site crossover | up to 2 days | Rate of access site crossover - if the initial access point fails physician can perform the procedure using other access site of his/her choice This data point is captured on the eCRF |
| Secondary | Total procedural time | up to 2 days | Total procedural time defined as the time between initiation of local anesthesia to sheath removal - information captured on the eCRF |
| Secondary | Sheath insertion time | up to 2 days | Sheath insertion time recorded in the eCRF and defined as when puncture with the introducer needle first attempted until the time when introducer sheath is successfully inserted |
| Secondary | Puncture site bleeding according to EASY criteria | up to 5 days | Puncture site bleeding according to EASY criteria |
| Secondary | Overall bleeding according to BARC criteria | up to 5 days | Overall bleeding according to BARC criteria |
| Secondary | Vascular access-site complication | up to 5 days | Vascular access-site complication documented on the eCRF. It is composed by the rate of vessel perforation after occlusion requiring intervention, arterial dissection, pseudoaneurysm, and local haematoma |
| Secondary | Rate of radial artery spasm | up to 2 days | Rate of radial artery spasm captured in the eCRF. Radial arety spasm is defined as an inability to manipulate the guidewire or catheter in a smooth and pain-free manner and also as an inability to remove the sheath in a similar way at the end of the procedure |
| Secondary | Rate of distal radial artery occlusion (dRAO) | up to 5 days | Rate of distal radial artery occlusion (dRAO) by doopler ultrasound and capture in the eCRF |
1 to 10 of 13Source ClinicalTrials.gov
See all 13 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers4
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT04171570
GET https://conductscience.org/api/trials/v1/NCT04171570/registered